Revenue growth of over 10% was primarily organic, fueled by broad clinical demand across physician, hospital, and consumer channels. Strategic collaborations with Corewell Health and Fresenius Medical Care contributed 9% to total volume, demonstrating the success of the Co-Lab partnership model. Revenue per requisition increased by 2.9% (excluding business mix impacts), driven by a higher number of tests per requisition and a shift toward high-value advanced diagnostics. The physician channel saw high single-digit growth due to expanded health plan access and increased business with existing customers in prevention and wellness. Advanced diagnostics in brain health, cardiometabolic, and oncology grew by double digits, reflecting a multi-biomarker approach to chronic disease management.